Chargement en cours...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Chinês |
| Publié: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| Collection: | Chinese Journal of Lung Cancer |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|